Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether apadenoson is as effective as adenosine when used
as a pharmacological stress agent in myocardial SPECT-imaging (SPECT-MPI)to detect defects in
the supply of blood to the heart muscle (myocardial perfusion defects). The study will also
look at whether apadenoson is better tolerated than adenosine when used in SPECT-MPI.